|Phone||+47 22 54 59 40|
|Description||International venture capital investment|
NeoMed Management is an international venture capital investment firm, exclusively focused on the healthcare industry. Founded in 1997, NeoMed has established five funds to date.
NeoMed invests in emerging companies with outstanding growth prospects. These companies are developing innovative and proprietary medical products that address substantial market opportunities in the pharmaceutical, medical device and diagnostics industries.
NeoMed has a multi-stage investment approach and invests at all stages of development from start-up to later stage growth financings. Since inception, NeoMed has successfully invested in more than 30 companies in Europe, including Scandinavia, Switzerland, Germany and the UK, and in North America.
From offices in Norway and Switzerland, NeoMed’s experienced investment team works closely with its entrepreneurs and a broader industry network to support the growth of its portfolio companies.
NeoMed is currently focusing on NeoMed Innovation IV L.P. and NeoMed Innovation V L.P.
|InDex Pharmaceuticals||2/2014||Private Equity||$20M||3|
|JenaValve Technology||7/2013||Series C||$62.5M||8|
|Vessix Vascular||8/2011||Series B||$23M||4|
|Vessix Vascular||10/2010||Venture Round||$4.7M||1|